Quantum Technology – Disclosing the Invention

The UK Intellectual Property Office recently had to decide whether the invention in a patent application claiming the production of quantum bits (or qubits) was sufficiently disclosed. The Hearing Officer confirmed the decision of the Examiner that the description was deficient and the invention was therefore not capable of industrial...

European Fund supporting IP for SMEs

The European Commission has implemented a fund to support European Union based small and medium-sized enterprises to obtain and exploit intellectual property rights, such as patents, trademarks and designs. The way the fund operates is slightly different from country to country. Generally, it provides support to SMEs of up to...

Patenting an Artificial Intelligence Invention – guidance from the US Patent Office

In 2019, the US Patent and Trademark Office drafted detailed guidance for the patent software invention. The 2019 Revised Patent Subject Matter Eligibility Guidance included one example (no 39) which was directed towards a method for training a neural network for facial detection. The example was very simple - the...

Patenting Software Modules

One of the biggest challenges in writing patents for computer-implemented inventions (CII) or "software patents" is the level of disclosure that is required. A patent examiner can reject the patent application in Europe for lack of enabling disclosure (as we have previously reported here) or for "indefiniteness" in the United...

What is a “Continuation” Patent Application?

A "continuation application" in the United States is an additional patent application filed by the same applicant as the original pending "parent" patent application to pursue different claims as in the parent application. The continuation application uses the same specification as the parent application and enjoys the same priority date...

Quantum Entanglement and Patent Protection

Quantum Entanglement and Patent Protection Quantum computing may well represent the next challenge in obtaining patent protection, as indicated by a recent decision from the US Court of Appeal of the Federal Circuit upholding a decision by the US Patent Office to reject four patent applications allegedly based on the...

Patents and Clinical Trials

It was almost inevitable that there would be allegations of patent infringement on solutions to address the Covid19 pandemic and IP Watchdog has recently highlighted the allegation by Allele Biotechnology and Pharmaceutical's complaint that the Covid19 vaccine manufacturers infringed Allele's US Patent 10,221221 covering a tag used to track vaccine...